Patents by Inventor Daniel M. LaFontaine

Daniel M. LaFontaine has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110301705
    Abstract: A cardiac valve with a support frame having a first end member and a second end member opposing the first end member in a substantially fixed distance relationship, and a cover extending over the support frame to allow for unidirectional flow of a liquid through the valve.
    Type: Application
    Filed: August 22, 2011
    Publication date: December 8, 2011
    Applicant: BOSTON SCIENTIFIC SCIMED, INC.
    Inventors: Mark L. Jenson, William J. Drasler, Daniel M. Lafontaine
  • Publication number: 20110282272
    Abstract: Devices and methods for cooling vessel walls to inhibit restenosis in conjunction with medical procedures such as coronary artery angioplasty. Stenosed vessel walls can be cooled prior to angioplasty, after angioplasty, or both. The invention is believed to inhibit restenosis through cooling to a temperature near freezing, preferably without causing substantial vessel wall cell death. One catheter device includes a distal tube region having coolant delivery holes radially and longitudinally distributed along the distal region. In some devices, holes spray coolant directly onto the vessel walls, with the coolant absorbed into the blood stream. In other embodiments, a balloon or envelope is interposed between the coolant and the vessel walls and the coolant returned out of the catheter through a coolant return lumen. Some direct spray devices include an occlusion device to restrict blood flow past the region being cooled. Pressure, temperature, and ultrasonic probes are included in some cooling catheters.
    Type: Application
    Filed: August 1, 2011
    Publication date: November 17, 2011
    Applicant: BOSTON SCIENTIFIC SCIMED, INC.
    Inventor: DANIEL M. LAFONTAINE
  • Publication number: 20110270331
    Abstract: The various embodiments disclosed herein relate to combination heart assist systems, methods, and devices that include both an electrical therapy device and a mechanical heart assist device. Various operational modes can be implemented using these embodiments, including a synchronized pacing mode, an internal CPR mode, and an internal workout mode.
    Type: Application
    Filed: April 1, 2011
    Publication date: November 3, 2011
    Applicant: SUNSHINE HEART COMPANY PTY LTD
    Inventors: William Suttle Peters, Rodney G. Parkin, David Rosa, Daniel M. Lafontaine, William T. Abraham, Benjamin Sun
  • Patent number: 8048066
    Abstract: Cryotreatment devices and methods of ablating tissue within the body are disclosed. A cryotreatment device in accordance with an exemplary embodiment of the present invention includes an elongated member having one or more needle-like ablation tips configured to induce necrosis at a target site within the heart. A cooling fluid such as a cryogen may be injected through a lumen extending into the distal portion of the device. The ablation tips can be configured to pierce and ablate surrounding tissue, blocking electrical stimuli that can cause fibrillations or other arrhythmias of the heart. The device may also include means for controlling the transmural depth at which the ablation tips are inserted into the cardiac tissue. Methods of forming a contiguous line of conduction block in accordance with the present invention are also disclosed.
    Type: Grant
    Filed: June 16, 2009
    Date of Patent: November 1, 2011
    Assignee: Boston Scientific Scimed, Inc.
    Inventor: Daniel M. Lafontaine
  • Patent number: 8050774
    Abstract: Apparatus, system, and method that include a pacing apparatus having a stent electrode through which pulses of electrical current can be delivered. Stent electrodes receive energy for generating the electrical current from a variety of sources. Sources include from one or more induction coils that can form at least a portion of the stent. Sources can also include an implantable pulse generator coupled to a lead through which pulses of the electrical current are supplied to the stent electrodes.
    Type: Grant
    Filed: December 22, 2005
    Date of Patent: November 1, 2011
    Assignee: Boston Scientific Scimed, Inc.
    Inventors: Graig L. Kveen, Roger N. Hastings, Anupama Sadasiva, Vitaly N. Shapovalov, Daniel M. Lafontaine
  • Patent number: 8012147
    Abstract: Devices and methods for cooling vessel walls to inhibit restenosis in conjunction with medical procedures such as coronary artery angioplasty. Stenosed vessel walls can be cooled prior to angioplasty, after angioplasty, or both. The invention is believed to inhibit restenosis through cooling to a temperature near freezing, preferably without causing substantial vessel wall cell death.
    Type: Grant
    Filed: April 12, 2007
    Date of Patent: September 6, 2011
    Assignee: Boston Scientific Scimed, Inc.
    Inventor: Daniel M. Lafontaine
  • Patent number: 8002824
    Abstract: A cardiac valve with a support frame having a first end member and a second end member opposing the first end member in a substantially fixed distance relationship, and a cover extending over the support frame to allow for unidirectional flow of a liquid through the valve.
    Type: Grant
    Filed: July 23, 2009
    Date of Patent: August 23, 2011
    Assignee: Boston Scientific Scimed, Inc.
    Inventors: Mark L. Jenson, William J. Drasler, Daniel M. Lafontaine
  • Patent number: 7942897
    Abstract: A closure device closes an opening in a body cavity. The closure device includes an elongate delivery member and a closure component which is removably connected to the distal end of the delivery member. The closure component has a collapsible backing movable between a non-collapsed position and a collapsed position. The closure component also includes a plurality of fibrous tissue engaging members disposed on the backing and oriented in a non-engaging orientation when traveling in a distal direction and in an engaging orientation when traveling in a proximal direction. The fibrous tissue engaging members become entangled in the backing when the backing is in the collapsed position.
    Type: Grant
    Filed: July 10, 2003
    Date of Patent: May 17, 2011
    Assignee: Boston Scientific Scimed, Inc.
    Inventor: Daniel M. Lafontaine
  • Publication number: 20110087204
    Abstract: A cryoplasty catheter and method for preventing or slowing reclosure of a lesion following angioplasty. The cryoplasty catheter includes a shaft having proximal and distal ends and a dilatation balloon disposed at the distal end. An intake lumen and exhaust lumen are defined by the shaft to deliver coolant to the balloon and to exhaust or drain coolant from the balloon. The method in accordance with the present invention includes cooling a lesion to aid in remodeling the lesion through dilatation and/or freezing a portion of the lesion adjacent the dilatation balloon to kill cells within the lesion to prevent or retard restenosis.
    Type: Application
    Filed: December 14, 2010
    Publication date: April 14, 2011
    Applicant: BOSTON SCIENTIFIC SCIMED, INC.
    Inventor: DANIEL M. LAFONTAINE
  • Publication number: 20110087275
    Abstract: A device for closing wounds such as openings in blood vessels as well as a method of doing so are disclosed. The device employs a fabric wrapped around an expandable frame both of which are inserted into a blood vessel through an introducer sheath. Once inserted, the expandable frame expands thereby expanding the fabric therewith. The fabric is made from a bioabsorbable material and includes a plurality of microhooks extending therefrom. One suitable material is polylactic acid fiber. Upon retraction of the device, the microhooks engage the adventitia surrounding the blood vessel causing the fabric to remain in position sealing the opening even after the expandable member is retracted and removed as well as the introducer sheath As the fabric is made from a bioabsorbable material, the device can remain in place even after hemostasis is reached and eventually dissolve within the body.
    Type: Application
    Filed: December 17, 2010
    Publication date: April 14, 2011
    Applicant: BOSTON SCIENTIFIC SCIMED, INC.
    Inventor: Daniel M. LaFontaine
  • Patent number: 7875054
    Abstract: A device for closing wounds such as openings in blood vessels as well as a method of doing so are disclosed. The device employs a fabric wrapped around an expandable frame both of which are inserted into a blood vessel through an introducer sheath. Once inserted, the expandable frame expands thereby expanding the fabric therewith. The fabric is made from a bioabsorbable material and includes a plurality of microhooks extending therefrom. One suitable material is polylactic acid fiber. Upon retraction of the device, the microhooks engage the adventitia surrounding the blood vessel causing the fabric to remain in position sealing the opening even after the expandable member is retracted and removed as well as the introducer sheath As the fabric is made from a bioabsorbable material, the device can remain in place even after hemostasis is reached and eventually dissolve within the body.
    Type: Grant
    Filed: October 1, 2007
    Date of Patent: January 25, 2011
    Assignee: Boston Scientific Scimed, Inc.
    Inventor: Daniel M. LaFontaine
  • Patent number: 7854755
    Abstract: A catheter including an elongate body, a first cutting head and a second cutting head both having a blade, where the blades moves relative each other to provide a shearing action for cardiac tissue. The catheter can further include a stent positioned over an inflatable balloon, where the inflatable balloon can deploy the expandable stent over sheared cardiac tissue. The catheter can further be included in a system having a sheath, where at least a part of the catheter resides in the lumen of the sheath. The sheath further includes a cardiac valve and an expandable filter. The sheath can move relative the cardiac valve and the expandable filter to deploy the cardiac valve and at least a portion of the expandable filter proximal the inflatable balloon and the expandable stent.
    Type: Grant
    Filed: February 1, 2005
    Date of Patent: December 21, 2010
    Assignee: Boston Scientific Scimed, Inc.
    Inventors: Daniel M. Lafontaine, Mark L. Jenson, William J. Drasler
  • Patent number: 7850681
    Abstract: A cryoplasty catheter and method for preventing or slowing reclosure of a lesion following angioplasty. The cryoplasty catheter includes a shaft having proximal and distal ends and a dilatation balloon disposed at the distal end. An intake lumen and exhaust lumen are defined by the shaft to deliver coolant to the balloon and to exhaust or drain coolant from the balloon. The method in accordance with the present invention includes cooling a lesion to aid in remodeling the lesion through dilatation and/or freezing a portion of the lesion adjacent the dilatation balloon to kill cells within the lesion to prevent or retard restenosis.
    Type: Grant
    Filed: February 17, 2006
    Date of Patent: December 14, 2010
    Assignee: Boston Scientific Scimed, Inc.
    Inventor: Daniel M. LaFontaine
  • Patent number: 7832406
    Abstract: Devices and methods for creating a series of percutaneous myocardial revascularization (PMR) channels in the heart. One method includes forming a pattern of channels in the myocardium leading from healthy tissue to hibernating tissue. Suitable channel patterns include lines and arrays. One method includes anchoring a radiopaque marker to a position in the ventricle wall, then using fluoroscopy repeatedly to guide positioning of a cutting tip in the formation of multiple channels. Another method uses radiopaque material injected into each channel formed, as a marker. Yet another method utilizes an anchorable, rotatable cutting probe for channel formation about an anchor member, where the cutting probe can vary in radial distance from the anchor. Still another method utilizes a multiple wire radio frequency burning probe, for formation of multiple channels simultaneously. Still another method utilizes liquid nitrogen to cause localized tissue death.
    Type: Grant
    Filed: July 28, 2005
    Date of Patent: November 16, 2010
    Assignee: Boston Scientific Scimed, Inc.
    Inventors: Louis Ellis, Daniel M. Lafontaine, Roger N. Hastings, Lauri DeVore
  • Publication number: 20100234884
    Abstract: A closure device closes an opening in a body cavity. The closure device includes a closure member that has an external, tissue-engaging surface formed with tissue engaging surface irregularities. An elongate member is disconnectably connected to the closure member.
    Type: Application
    Filed: May 28, 2010
    Publication date: September 16, 2010
    Applicant: BOSTON SCIENTIFIC SCIMED, INC.
    Inventors: Daniel M. Lafontaine, Mark T. Ungs, William J. Drasler, Sheng-Ping (Samuel) Zhong
  • Patent number: 7722666
    Abstract: A cardiac valve with a first anchor frame and a cover on the first anchor frame for unidirectional flow of a liquid through the valve.
    Type: Grant
    Filed: April 15, 2005
    Date of Patent: May 25, 2010
    Assignee: Boston Scientific Scimed, Inc.
    Inventor: Daniel M. Lafontaine
  • Publication number: 20100100173
    Abstract: A cardiac valve with a first anchor frame and a cover on the first anchor frame for unidirectional flow of a liquid through the valve.
    Type: Application
    Filed: December 28, 2009
    Publication date: April 22, 2010
    Applicant: Boston Scientific Scimed, Inc.
    Inventor: Daniel M. Lafontaine
  • Patent number: 7674256
    Abstract: Some embodiments of the invention relate to a system for treating tissue internal to a body, such as heart tissue. For example, the system may be used to ablate tissue as a treatment for atrial fibrillation. In certain embodiments, the system is capable of causing scar tissue to form in ostial areas of the atrium rather than inside the pulmonary vein. In such embodiments, the system may include a tissue treatment member that is operable to form an annular area of ablated tissue along the outer portion of the ostium in an area known as the antrum.
    Type: Grant
    Filed: March 17, 2005
    Date of Patent: March 9, 2010
    Assignee: Boston Scientific SciMed, Inc.
    Inventors: Nassir Marrouche, Daniel M. Lafontaine
  • Publication number: 20090299358
    Abstract: Cryotreatment devices and methods of ablating tissue within the body are disclosed. A cryotreatment device in accordance with an exemplary embodiment of the present invention includes an elongated member having one or more needle-like ablation tips configured to induce necrosis at a target site within the heart. A cooling fluid such as a cryogen may be injected through a lumen extending into the distal portion of the device. The ablation tips can be configured to pierce and ablate surrounding tissue, blocking electrical stimuli that can cause fibrillations or other arrhythmias of the heart. The device may also include means for controlling the transmural depth at which the ablation tips are inserted into the cardiac tissue. Methods of forming a contiguous line of conduction block in accordance with the present invention are also disclosed.
    Type: Application
    Filed: June 16, 2009
    Publication date: December 3, 2009
    Inventor: Daniel M. Lafontaine
  • Publication number: 20090287298
    Abstract: A cardiac valve with a support frame having a first end member and a second end member opposing the first end member in a substantially fixed distance relationship, and a cover extending over the support frame to allow for unidirectional flow of a liquid through the valve.
    Type: Application
    Filed: July 23, 2009
    Publication date: November 19, 2009
    Applicant: BOSTON SCIENTIFIC SCIMED, INC.
    Inventors: Mark L. Jenson, William J. Drasler, Daniel M. Lafontaine